Lung Cancer: Targets and Therapy
Volume 13, 2022 - Issue
Open access
220
Views
1
CrossRef citations to date
0
Altmetric
REVIEW
A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib
Danielle Brazel1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USAView further author information
, Zhaohui Arter1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USAView further author information
& Misako Nagasaka1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA;2 Chao Family Comprehensive Cancer Center, Orange, CA, USA;3 St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence[email protected]
https://orcid.org/0000-0001-5308-615XView further author information
Pages 75-80
|
Received 25 Jul 2022, Accepted 21 Oct 2022, Published online: 10 Nov 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.